http://www.mersana.com
Mersana Therapeutics, Inc. Company Intro
Technology Mersana has developed highly differentiated and innovative antibody-drug conjugate (ADC) platforms, with both cytotoxic and immunostimulatory payloads, that allow for customization and optimization of ADCs for a given target and indication. As a result, we are designing ADCs to overcome the limitations of first-generation platforms by delivering therapeutics with greater efficacy and tolerability to […]
Industry
Healthcare
Mersana Therapeutics, Inc. Headquaters
840 Memorial Drive
Cambridge,02139
United States
Mersana Therapeutics, Inc. Share price
22 Jan 2021 02:08 GMT
$21.18
-0.04 (-0.19 %)
Mersana Therapeutics, Inc. Market cap
$1.373 B
WMC RANKING
2021
Mersana Therapeutics, Inc. # 254
BiotechnologyLatest Mersana Therapeutics, Inc. News
12 Jan 2021
Global Antibody Drug Conjugate Market by Market Share, Vendors, Growth Rate, Analysis, Product Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics
... Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., ... Genentech, Heidelberg Pharma, Immunomedics, Mersana Therapeutics, ...
12 Jan 2021
Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN) lost ...
Mersana Therapeutics, Inc. (NASDAQ:MRSN) has a beta value of 2.51 and has seen 1,219,613 shares traded in the last trading session. The company, currently ...
12 Jan 2021
Global Antibody Drug Conjugate Market by Market Share, Vendors, Growth Rate, Analysis, Product Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Immunomedics
... Type, Revenue| Bayer AG, Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., ... Genentech, Heidelberg Pharma, Immunomedics, Mersana Therapeutics, ...
WMC Market Score
WMC Market to Revenue Score
Mersana Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Mersana Therapeutics, Inc. | USD | $859 | $76,808 | $-75,449 | $14,540B | 254 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $578,630B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,010B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $615,510B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $276,870B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Mersana Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Post vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Mersana Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Mersana Therapeutics, Inc. | 0.01 | 1.69 | 4.60 | 0 | 0 | 0 | 3.23 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.01 | 28.87 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.23 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.79 | 86 | 0 | 0 | 99.87 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
